Cognate BioServices Is Now Part of Charles River

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics and Vigene Biosciences, join Charles River to offer customers a single, trusted partner. We have supported the development of 15 FDA-approved cell and gene therapies and have conducted more than 1,000 studies in this field over the past year.

Connect With Us

Cognate BioServices

Explore Our Cell and Gene Therapy CDMO Solutions

Plasmid DNA Manufacturing

Viral Vector Manufacturing

Cell Therapy Manufacturing

Off-the-Shelf Plasmid Products

Viral Vector Packaging

Gene Therapy Manufacturing

 

Photo of the exterior of the Alderley Park, UK Cell and Gene Therapy CDMO Facility

Cell and Gene Therapy CDMO Facilities

Accelerate the development of your product and ensure it meets the highest regulatory standards while maintaining efficient production timelines through our integrated global network of contract development and manufacturing organization (CDMO) facilities and testing sites.

Explore our Sites

Still have questions for our cell and gene therapy specialists?
Connect With Us